A Study to Investigate the Effect of the CYP3A Inducer Phenytoin and the CYP3A Inhibitor Itraconazole on the Pharmacokinetics of BGB-58067 in Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy Volunteers

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cmax Clinical Research, Adelaide, South Australia, Australia

Study leads

Study Director
BeOne Medicines

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules

Healthy Volunteers

Abroad (travel likely)RecruitingEARLY_PHASE1

Hefei, China

Study of Food Effects of VV913 Capsules in Chinese Healthy Volunteers

Healthy Volunteers

Abroad (travel likely)RecruitingPHASE1

Hefei, China

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

Healthy Volunteer · Pharmacokinetics · Safety

Abroad (travel likely)RecruitingPHASE1

Lenexa, United States

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients

Epilepsy · Healthy Volunteer

Abroad (travel likely)RecruitingPHASE1

Tucson, United States · DeLand, United States